Their study also revealed that ANA positivity was associated with cardiovascular death so it is essential to monitor patients with positive ANA titers for cardiovascular disease, even if they do not meet the criteria for the traditional risk factors. This evidence concerns the gene BTG3 and cardiovascular disorder.